Open call for tenders

Open-House-Verträge 2026-3

Pharmaceutical products · for AOK Bremen/Bremerhaven · Germany · published in German

What the buyer wants

Open-House-Verträge für diverse Wirkstoffe ab frühestens 01.12.2026 bis 30.11.2028.

30 lots

  1. Abatacept - ATC Code L04AA24
  2. Aprepitant - ATC Code A04AD12
  3. Brivaracetam - ATC Code N03AX23
  4. Budesonid - ATC Code A07EA06
  5. Ciclopirox - ATC Code D01AE14
  6. Clonidin - ATC Code C02AC01 & S01EA04
  7. Dalbavancin - ATC Code J01XA04
  8. Dapagliflozin - ATC Code A10BK01
  9. Darbepoetin alfa - ATC Code B03XA02
  10. Erythropoetin - ATC Code B03XA01
  11. Filgrastim - ATC Code L03AA02
  12. Follitropin alfa - ATC Code G03GA05
  13. Follitropin beta - ATC Code G03GA06
  14. Glyceroltrinitrat - ATC Code C01DA02
  15. Golimumab - ATC Code L04AB06
  16. Guselkumab - ATC Code L04AC16
  17. Indacaterol + Glycopyrronium - ATC Code R03AL04
  18. Interferon beta 1a-sub - ATC Code L03AB07
  19. Ipratropiumbromid - ATC Code R03BB01, R01AX03, C01CX15
  20. Melatonin - ATC Code N05CH01
  21. Meropenem - ATC Code J01DH02
  22. Mesalazin - ATC Code A07EC02
  23. Metronidazol - ATC Code G01AF01 & P01AB01
  24. Miglustat - ATC Code A16AX06
  25. Naproxen - ATC Code M01AE02
  26. Natalizumab SC - ATC Code L04AA23
  27. Nevirapin - ATC Code J05AG01
  28. Raltegravir - ATC Code J05AJ01
  29. Rasagilin - ATC Code N04BD02
  30. Rifaximin - ATC Code A07AA11

Companies that won similar tenders

Companies that won public tenders in the same category (Pharmaceutical products) since 2024, according to EU award notices. Likely competitors, or partners for a joint offer.

and 4 more.